Statistics
Publications
48
Citations
17.1K
H-Index
33
Active since
1983
Tom Thurén is an author at Novartis (Switzerland) specializing in medicine, biochemistry, and pharmacology.
Publications per year
1983–2022
48
48
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 9.1K citations · Full text
Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +13
Paul M. Ridker, Jean MacFadyen, Peter Libby et al. · The Lancet · 2017 · 886 citations · Full text
Paul M. Ridker, Tom Thurén, Andrew Zalewski et al. · American Heart Journal · 2011 · 793 citations · Full text
Medicine, Immunology, Pharmacology +14
1–5 of 48